Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of Proskauer’s private equity group, has joined Accelmed as a partner.
“Eric and Steve are both deeply experienced and well-respected in their fields, are of high character, and, most importantly, share Accelmed’s commitment to seeking to provide strong risk-adjusted returns to investors by capturing dynamic HealthTech investment opportunities,” Dr. Uri Geiger, founder and managing partner of Accelmed, said in a statement.
Mr. Rubin said there is high demand currently for partnerships between innovative HealthTech companies and value-add investment partners such as Accelmed.
In addition Accelmed also bolstered its executives network with the additions of Lewis Pell and Stanley Stern, veterans in medical technology and investment banking, respectively. They will assist Accelmed in identifying and analyzing potential investment opportunities.
The expansion of Accelmed’s senior team and executives network follows the recent close of Accelmed Fund II at a hard cap of $400-million, and the firm’s investments in TearLab, NeuroPace, which recently went public, and MedMinder.
